Rodrigo Neiva

The Influence of the Bucco-Palatal Distance on Sinus Augmentation Outcomes

BACKGROUND Maxillary sinus augmentation is one of the most reliable implant site development options to increase vertical bone height. However, graft consolidation requires adequate angiogenesis and migration of cells involved in osteogenesis and bone remodeling. It is speculated that these biologic events are greatly determined by the dimensions of the maxillary sinus cavity. Hence, the purpose of this study is to assess the influence of the distance from the lateral to the medial wall of the maxillary sinus on the outcomes of sinus augmentation procedures. METHODS A total of 25 patients in need of sinus augmentation were recruited for the study. After initial examination, customized radiographic and surgical guides were fabricated and a cone-beam computerized tomography scan was obtained per patient. The bucco-palatal distance (BPD) was measured at 8, 10, and 12 mm from the alveolar crest. Sinus grafting was performed by a lateral window approach using a particulated allograft material. Patients were followed-up for 6 months. At the time of implant placement, bone core biopsies were harvested using the radiographic-surgical guide. Sections of the bone cores at 8, 10, and 12 mm from the alveolar crest were histomorphometrically analyzed. The proportion of vital bone (%VB) was correlated with the BPD using a statistical model. RESULTS Twenty-one patients underwent sinus augmentation for a total of 24 sinuses; however, the data analyzed contained only one sinus per patient. One sinus developed an infection after grafting, resulting in a 96% success rate for the sinus grafting procedure. Twenty sinuses were used in the final statistical analysis. Histomorphometric analysis revealed that mean %VB was 22.71 +/- 19.08, mean percent of remaining allograft was 23.39 +/- 20.85, and average percent of non-mineralized connective tissue was 53.90 +/- 13.23. Analysis of the correlation between %VB and BPD by linear regression, using the actual values of BPD showed a strong negative association (R(2) = 0.141; P <0.001). CONCLUSION The findings suggest that the %VB formation after maxillary sinus augmentation is inversely proportional to the sinus BPD.

Comparison of Dermal Matrix and Polytetrafluoroethylene Membrane for Socket Bone Augmentation: A Clinical and Histologic Study

BACKGROUND Remodeling and resorption of the alveolar crest, specifically at the buccal aspect, characterize the healing extraction socket. These result in narrowing and shortening of the alveolar ridge, which compromise esthetics and complicate restoration. Alveolar ridge augmentation has been proposed to facilitate future site restoration by minimizing ridge resorption. Therefore, the purpose of this study was to compare extraction socket healing and alveolar ridge alteration after socket augmentation using bone allograft covered with an acellular dermal matrix (ADM) or polytetrafluoroethylene (PTFE) membrane. METHODS Twenty non-smoking healthy subjects were selected. Each subject required maxillary premolar, canine, or central incisor tooth extraction. The extraction sites were debrided and grafted with a mineralized bone allograft that was covered with an ADM or PTFE membrane. Postoperative appointments were scheduled at 2, 4, and 8 weeks. After 16 weeks of healing, final measurements were performed, and trephine core biopsies were obtained for histomorphometric analysis. Implants were placed immediately after biopsy harvesting. RESULTS Eighteen subjects completed the study. All sites healed without adverse events and allowed for implant placement. PTFE membranes exfoliated prematurely, with an average retention time of 16.6 days, whereas the ADM membranes appeared to be incorporated into the tissues. Buccal plate thickness loss was 0.44 and 0.3 mm, with a vertical loss of 1.1 and 0.25 mm, for ADM and PTFE, respectively. Bone quality assessment indicated D3 to be the most prevalent (61%). Histomorphometric analysis revealed 41.81% versus 47.36% bone, 58.19% versus 52.64% marrow/fibrous tissue, and 13.93% versus 14.73% particulate graft remaining for ADM and PTFE, respectively. No statistical difference was found between the two treatment groups for any of the parameters. CONCLUSION All sites evaluated showed minimal ridge alterations, with no statistical difference between the two treatment modalities with respect to bone composition and horizontal and vertical bone loss, indicating that both membranes are suitable for alveolar ridge augmentation.

Angiogenic Biomarkers and Healing of Living Cellular Constructs

The use of intra-oral soft-tissue-engineered devices has demonstrated potential for oral mucosa regeneration. The aim of this study was to investigate the temporal expression of angiogenic biomarkers during wound healing of soft tissue reconstructive procedures comparing living cellular constructs (LCC) with autogenous free gingival grafts. Forty-four human participants bilaterally lacking sufficient zones of attached keratinized gingiva were randomly assigned to soft tissue surgery plus either LCC or autograft. Wound fluid samples were collected at baseline and weeks 1, 2, 3, and 4 post-operatively and analyzed for a panel of angiogenic biomarkers: angiogenin (ANG), angiostatin (ANT), PDGF-BB, VEGF, FGF-2, IL-8, TIMP-1, TIMP-2, GM-CSF, and IP-10. Results demonstrated a significant increase in expression of ANT, PDGF-BB, VEGF, FGF-2, and IL-8 for the LCC group over the autograft group at the early stages of wound repair. Although angiogenic biomarkers were modestly elevated for the LCC group, no clinical correlation with wound healing was found. This human investigation demonstrates that, during early wound-healing events, expression of angiogenic-related biomarkers is up-regulated in sites treated with LCC compared with autogenous free gingival grafts, which may provide a safe and effective alternative for regenerating intra-oral soft tissues (ClinicalTrials.gov number, NCT01134081).

Effect of Adjunctive Systemic Azithromycin With Periodontal Surgery in the Treatment of Chronic Periodontitis in Smokers: A Pilot Study

BACKGROUND Along with conventional surgical therapy, systemic antibiotics may provide more effective treatment in smokers by targeting tissue-invasive bacteria. The aim of this randomized, placebo-controlled, double-masked clinical trial was to evaluate the adjunctive effects of systemic azithromycin (AZM) in combination with periodontal pocket reduction surgery in the treatment of chronic periodontitis in smokers. METHODS Thirty patients with a greater than one pack/day smoking habit and generalized moderate to severe chronic periodontitis were randomized to the test (surgery plus 3 days of AZM, 500 mg) or control group (surgery plus 3 days of placebo). Full-mouth probing depth (PD), clinical attachment level (CAL), bleeding on probing (BOP), gingival index (GI), plaque index, and wound healing indices (WHI) were assessed at baseline and at 2 weeks and 1, 3, and 6 months following surgical intervention. Plaque and gingival crevicular fluid were collected for trypsin-like enzyme activity (benzoyl-dl-arginine naphthylamine) and bone biomarker (crosslinked telopeptide of type I collagen [ICTP]) analyses, respectively, at baseline, 2 weeks, and 1, 3, and 6 months. RESULTS Surgical treatment of moderate (PD = 4 to 6 mm) and deep (PD > 6 mm) pockets significantly improved clinical parameters of treated and untreated teeth (CAL gain, PD reduction, and reduction of BOP). The additional use of AZM did not enhance this improvement nor did it promote reduction of ICTP levels. Compared to the control group, the test group had significantly better WHI scores at 1 month, significantly less GI at 2 weeks, and sustained reductions of red-complex bacteria with trypsin-like enzyme activity at 3 months. For non-surgery teeth, only the test group showed significant gains in overall CAL compared to baseline. CONCLUSIONS The findings of this pilot study demonstrated that in heavy smokers, adjunctive systemic AZM in combination with pocket reduction surgery did not significantly enhance PD reduction or CAL gain. However, the clinical value of adjunctive AZM may be appreciated by more rapid wound healing, less short-term gingival inflammation, and sustained reductions of periopathogenic bacteria. More expanded studies are recommended to better determine the clinical effects of adjunctive AZM in patients who smoke.

Living Cellular Construct for Increasing the Width of Keratinized Gingiva: Results From a Randomized, Within-Patient, Controlled Trial

BACKGROUND The standard of care for increasing keratinized gingiva adjacent to teeth that do not require root coverage is the free gingival graft (FGG). A pilot study indicated that the use of a living cellular construct (LCC) could be effective in this clinical scenario. METHODS A pivotal, multicenter, randomized, within-patient, controlled, open-label trial was conducted (N = 96 patients). After removing the mucosa and keratinized gingiva from the test site, either an LCC or FGG was applied. The primary efficacy endpoint was the ability of the LCC to regenerate ≥2 mm keratinized gingiva at 6 months. Secondary measures were the same color and texture as the adjacent tissue, a 1-mm width of keratinized gingiva at 6 months, patient treatment preference, surgical site sensitivity at 1 week, and patient-reported pain after 3 days. Safety was assessed by reports of adverse events. RESULTS At 6 months, the LCC regenerated ≥2 mm of keratinized gingiva in 95.3% of patients (81 of 85 patients; P <0.001 versus a 50% predefined standard). As expected, the FGG generated more keratinized gingiva than the LCC (4.57 ± 1.0 mm versus 3.2 ± 1.1 mm, respectively). The gingiva regenerated with the LCC matched the color and texture of the adjacent gingiva. All patients achieved ≥1 mm keratinized gingiva with the LCC treatment by 6 months, and more patients preferred treatment with the LCC than with the FGG. No difference in sensitivity or pain was noted between the treatments. The treatments were well tolerated, and reported adverse events were typical for this type of periodontal surgery. CONCLUSION The use of an LCC may provide a safe and effective therapy for augmenting the zone of keratinized gingiva.

Clinical and histologic outcomes after the use of a novel allograft for maxillary sinus augmentation: a case series.

Purpose:To document the clinical and histologic outcomes of sinus augmentation using a novel allogenic bone substitute as a sole grafting material. Materials:Patients in need of sinus augmentation before implant placement were recruited for this study. Sinus augmentation procedures were performed following a lateral approach, using a freeze-dried allograft as the only grafting material. Patients were followed up postoperatively for 6 months. Plaque score, wound healing, and patient discomfort were recorded at each follow-up visit. Implants were placed between 6 and 7 months after sinus augmentation and restored 6 months later. Bone core biopsy specimens were harvested at the time of implant placement and processed for histologic and histomorphometrical analysis. Vital bone, remaining allograft (RA) particles, and nonmineralized tissue percentages were assessed on each sample. Results were expressed as mean percentages with SD. Results:Of the 23 sinus patients, 20 patients underwent sinus augmentation surgery. All patients had satisfactory postoperative healing in the absence of complications. A total of 39 implants were placed. One implant failed and was replaced 3 months later. Histologic analysis revealed the presence of well-organized lamellar bone, in direct contact with RA particles. Mean vital bone was 23.02 ± 19.11%, mean RA was 22.25 ± 20.30%, and average nonmineralized tissue was 54.73 ± 13.51%. Conclusion:Clinical and histologic findings support the suitability of an allograft consisting of a combination of cortical and cancellous chips for sinus augmentation procedures.

Intraoral grafting of tissue-engineered human oral mucosa.

PURPOSE The primary objective of this study was to evaluate the safety of a tissue-engineered human ex vivo-produced oral mucosa equivalent (EVPOME) in intraoral grafting procedures. The secondary objective was to assess the efficacy of the grafted EVPOME in producing a keratinized mucosal surface epithelium. MATERIALS AND METHODS Five patients who met the inclusion criteria of having one mucogingival defect or a lack of keratinized gingiva on a nonmolar tooth, along with radiographic evidence of sufficient interdental bone height, were recruited as subjects to increase the width of keratinized gingiva at the defect site. A punch biopsy specimen of the hard palate was taken to acquire oral keratinocytes, which were expanded, seeded, and cultured on an acellular dermal matrix for fabrication of an EVPOME. EVPOME grafts were applied directly over an intact periosteal bed and secured in place. At baseline (biopsy specimen retrieval) and at 7, 14, 30, 90, and 180 days postsurgery, Plaque Index and Gingival Index were recorded for each subject. In addition, probing depths, keratinized gingival width, and keratinized gingival thickness were recorded at baseline, 30, 90, and 180 days. RESULTS No complications or adverse reactions to EVPOME were observed in any subjects during the study. The mean gain in keratinized gingival width was 3 mm (range, 3 to 4 mm). The mean gain in keratinized gingival thickness was 1 mm (range, 1 to 2 mm). No significant changes in probing depths were observed. CONCLUSION Based on these findings, it can be concluded that EVPOME is safe for intraoral use and has the ability to augment keratinized tissue around teeth. Future clinical trials are needed to further explore this potential.

Analysis of the influence of residual alveolar bone height on sinus augmentation outcomes.

INTRODUCTION Maxillary sinus augmentation is a predictable implant site development technique for posterior atrophic maxillary ridges. However, graft consolidation requires adequate angiogenesis and migration of osteogenic cells from native bone. Therefore, the amount of residual bone height (RBH) may play a role in the rate of graft maturation. The purpose of this study was to analyze the influence of RBH in the histomorphometric outcomes of maxillary sinus augmentation procedures. MATERIAL AND METHODS Patients in need of sinus augmentation were recruited for the study. Customized radiographic guides were fabricated and a cone-beam computerized tomography scan was obtained at baseline. Two examiners measured RBH on the scans at the locations marked by the radiographic guide. Sinus grafting was performed by a lateral window approach using a particulated mineralized allograft. Patients were followed up for 6 months. At the time of implant placement, bone core biopsies were harvested using the radiographic guide, which was converted into a surgical guide. Samples were histomorphometrically analyzed. Proportion of vital bone (%VB), remaining allograft particles (%RA), and non-mineralized tissue (%NMT) were quantified. Categorical analysis of correlation of RBH (<4 or ≥4 mm) with%VB and%RA was performed using a statistical model. RESULTS Twenty-one patients underwent sinus augmentation for a total of 21 sinuses. One patient developed an infection after grafting and was excluded. Histomorphometric analysis revealed that mean%VB was 20.47 ± 18.25, mean %RA was 29.04 ± 24.94, and average %NMT was 50.47 ± 12.76. No significant correlation between RBH and %VB (r = 0.016; P = 0.951), and RBH and % (r = 0.009; P = 0.971) was found. Similarly, categorical analysis of correlation showed no statistical significance. CONCLUSION These findings suggest that the remaining alveolar bone height does not appear to influence the maturation and consolidation of an allograft in the maxillary sinus.

The effect of healing abutment reconnection and disconnection on soft and hard peri-implant tissues: a short-term randomized controlled clinical trial.

PURPOSE It has been reported that multiple abutment disconnections and reconnections following implant placement may compromise the peri-implant mucosal seal and may lead to increased marginal bone loss. Thus, the aim of this study was to evaluate the effect of healing abutment disconnection and reconnection on soft and hard peri-implant tissues. MATERIALS AND METHODS Sixteen patients were included in this prospective randomized controlled clinical trial. Following one-stage implant placement, test group implants (n = 10) received a permanent abutment and control group implants (n = 11) received a healing abutment. After 2 months of healing, control group implants underwent a prosthetic protocol involving implant-level impressions and a two-time abutment disconnection and reconnection process prior to delivery of the definitive prosthesis. Test group implants underwent a prosthetic protocol involving abutment-level impressions without any abutment disconnection. Clinical parameters were recorded at 2 weeks, 2 months, 3 months, and 6 months, and marginal bone levels were assessed radiographically at implant placement, 3 months, and 6 months. RESULTS The overall survival rate from implant placement to the last follow-up visit was 100% for both groups. The mean marginal bone loss at the 6-month examination was 0.13 mm for test group implants and 0.28 mm for control group implants. There were no significant differences regarding changes in peri-implant mucosal dimensions between the two groups. CONCLUSION The present study indicates that implants receiving a final abutment at the time of implant placement exhibited minimal marginal bone loss and were similar to implants subjected to abutment disconnection and reconnection two times. Disconnection and reconnection of the abutment two times did not cause negative dimensional changes in the peri-implant mucosa.

Placement of implants with platform-switched Morse taper connections with the implant-abutment interface at different levels in relation to the alveolar crest: a short-term (1-year) randomized prospective controlled clinical trial.

PURPOSE This study sought to prospectively evaluate changes in marginal bone levels and soft tissue dimensions around platform-switched, Morse taper-connection implants placed with the implant-abutment interface (IAI) at different positions in relation to the alveolar crest. MATERIALS AND METHODS Thirty patients in need of single-tooth rehabilitations were randomly assigned to three groups based on the position of the IAI in relation to the alveolar crest at the time of implant placement. Implants in groups 0, 1, and 2 (n = 10 in each group) were placed at the bone level or 1 mm and 2 mm below the buccal aspect of the alveolar crest, respectively. Four months later, the implants were restored with crowns. Clinical parameters were recorded at 4 and 12 months, and marginal bone levels were assessed radiographically at placement, 4 months, and 12 months. RESULTS Mean marginal bone loss below the implant platform in group 0 implants was 0.18 ± 0.27 mm at 4 months and 0.27 ± 0.45 mm at 12 months. All implants in groups 1 and 2 exhibited no marginal bone loss below the implant platform, since the first bone-to-implant contact was located at or above the implant margin. At 12 months, implants in groups 1 and 2 exhibited greater mean bone loss above the implant platform compared to implants in group 0, but the differences were not statistically significant (group 0, 0.64 ± 0.49 mm; group 1, 0.81 ± 0.31 mm; group 2, 1.20 ± 0.68 mm). Implants in groups 1 and 2 exhibited a statistically significantly higher percentage of implant surfaces with bone on the implant platform compared to group 0 implants (90% versus 35%). CONCLUSIONS In the present study, differences in peri-implant bone responses existed for implants placed with the IAI at different locations in relation to the alveolar crest.